77
62. Khouzam, H. R.
The antidepressant nefazodone. A review of its pharmacology, clinical
efficacy,adverse effects, dosage, and administration.
J. Psychosoc. Nurs. Ment. Health. Serv. 38(8):20-5. (2000)
63. Kittayaphong, R., Cascio, W. E., Light, K. C., Sheffield, D., Golden, R. N.,
Finkel, J. B., Glekas, G., Koch, G. G., Sheps, D. S.
Heart rate variability in patients with coronary artery disease: Differences in
patients with higher and lower depression scores.
Psychosom. Med. 59, 231-235. (1997)
64. Kleiger, R. E., Miller, J. P., Moss, A. J. and the Multicenter Post-Infarction
Research Group.
Decreased heart rate variability and its association with increased mortality after
acute myocardial infarction.
Am. J. Cardiol. 59, 256-262. (1987)
65. Kraeplin, E., Barclay, R. M.
Manic-Depressive Insanity and Paranoia.
Edinburgh: E & S Livingstone. (1921)
66. Kuhn, R.
The treatment of depressive states with G-22355(imipramine hydrochloride).
Am. J. Psychiatry. 115, 459-464. (1958)
67. Lader, M.
Fluoxetine efficacy vs comparative drugs: an overview.
Br. J. Psychiatry. 153[suppl. 3],51-58. (1988)
68. LaRovere, M.T., Bigger, J. T. Jr., Marcus, F.I., Mortara, A., Schwartz, P.J.
Baroreflex sensitivity and heart-rate variability in prediction of total cardiac
mortality after myocardial infarction.
ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction)
Investigators.
Lancet. 14;351(9101):478-84. (1998)
69. Levine, A.B.
A simple test of cardiac function based upon the heart rate changes induced by
the Valsalva manoeuver.
Am. J. Cardiol. 18, 90-99. (1966)
70. Light, K. C., Kothandapani, R. V., Allen, M. T.
Enhanced cardiovascular and catecholamine responses in women with
depressive symptoms.
Int. J. Psychophysiol. 28, 157-166. (1998)
71. Low, P. A., Opfer-Gehrking, T. L.
Differential effects of amitriptyline on sudomotor, cardiovagal and adrenergic
function in human subjects.
Muscle. Nerve. 15, 1340-1344. (1992)
|
